American Eagle’s Partnership with CBD Producer Spurns Complaints from Concerned Parents
The wildly popular cannabinoid is creating lucrative opportunities for investors, but still maintains a dubious status with the Food & Drug Administration.
MORE STORIES LIKE THIS
Featured Franchise News
Featured Brand News
/story1/2710565/8d27c1b49f8d229337f891d1710953086382.jpg)

/story1/2731084/bf66466cbd4df59491d91e06fe1696541153.jpg)
/story1/2731616/1febe51044a7db8f2d114b9fda04993b3799.jpg)
/story1/2731599/1892c6e35f792878e270881ca55c97975627.jpg)
/story1/2731529/1771972647_2731529.png)
/story1/2731656/1773358186_2731656.png)
/story1/2731641/be2969049179e2a832b4cc361f3e9a2c5905.jpg)
/story1/2731655/e07022c7b432f2457d0f6801703f4e89797.jpg)
/story1/2731657/1773359223_2731657.png)
/story1/2731648/1773254218_2731648.png)
/story1/2731652/90c15969646222d4874843fd6215b75d8623.jpg)